Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Drug Research
Drug Delivery
Return to: PBR Home | Drug Research | Drug Delivery

Bedford recalls Vecuronium Bromide for Injection at hospital/user-level

PBR Staff Writer Published 29 June 2012

Bedford Laboratories has issued hospital/user-level voluntarily recall of Vecuronium Bromide for Injection preservative free, Lot 2067134, because of possible health risk.

The voluntary recall is being conducted due to the discovery of particulate matter, which has been recognized as a potential health hazard, in a small number of vials within the lot.

The adverse reactions due to particulate matter may include vein irritation and phlebitis, clinically occult pulmonary granulomas detected at routine autopsy examination, local tissue infarction, pulmonary dysfunction, occlusion of capillaries and arteries, anaphylactic shock and death.

Vecuronium Bromide is indicated as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Comments
Post a comment

Comments may be moderated for spam, obscenities or defamation.